The incidence of sarcopenia among hospitalized older patients: results from the Glisten study

Anna Maria Martone, Lara Bianchi, Pasquale Abete, Giuseppe Bellelli, Mario Bo, Antonio Cherubini, Francesco Corica, Mauro Di Bari, Marcello Maggio, Giovanna Maria Manca, Emanuele Marzetti, Maria Rosaria Rizzo, Andrea Rossi, Stefano Volpato, Francesco Landi, Anna Maria Martone, Lara Bianchi, Pasquale Abete, Giuseppe Bellelli, Mario Bo, Antonio Cherubini, Francesco Corica, Mauro Di Bari, Marcello Maggio, Giovanna Maria Manca, Emanuele Marzetti, Maria Rosaria Rizzo, Andrea Rossi, Stefano Volpato, Francesco Landi

Abstract

Background: New evidence is emerging on the importance of lean body mass during periods of illness and recovery. The preservation of lean body mass during such periods of intense stress impacts both patient and treatment outcomes. However, data concerning the incidence of sarcopenia among older people during hospitalization are scarce. The objective of this study was to evaluate the development of sarcopenia in a sample of hospitalized older subjects.

Methods: We used data of 394 participants from the multicentre Italian Study conducted by the Gruppo Lavoro Italiano Sarcopenia-Trattamento e Nutrizione (GLISTEN) in 12 Acute Care Wards (Internal Medicine and Geriatrics) of University Hospitals across Italy. This study was designed to determine the prevalence of sarcopenia at hospital admission and the change in muscle mass and strength during hospitalization. Sarcopenia was defined as low skeletal mass index (kg/m2 ) along with either low handgrip strength or slow walking speed [European Working Groups on Sarcopenia in Older People (EWGSOP) criteria]. Estimation of skeletal muscle mass was performed by bioelectrical impedance analysis (BIA).

Results: The mean age of the 394 enrolled patients (including 211 females who accounted for 53% of the sample) was 79.6 ± 6.4 years. Among those without sarcopenia at hospital admission, 14.7% of the study sample met the EWGSOP sarcopenia diagnostic criteria at discharge. The incidence of sarcopenia during hospitalization was significantly associated with the number of days spent in bed but was not correlated with the total length of hospital stay. In particular, patients who developed sarcopenia spent an average of 5.1 days in bed compared with 3.2 days for those with no sarcopenia at discharge (P = 0.02). Patients with sarcopenia showed a significantly lower body mass index compared with non-sarcopenic peers (25.0 ± 3.8 kg/m2 vs. 27.6 ± 4.9 kg/m2 , respectively; P < 0.001). Similarly, the skeletal mass index at admission was significantly lower among patients who developed sarcopenia during hospital stay.

Conclusions: Incident sarcopenia during hospital stay is relatively common and is associated with nutritional status and the number of days of bed rest.

Keywords: Acute care; Bed rest; Incidence; Malnutrition; Muscle.

© 2017 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders.

Figures

Figure 1
Figure 1
Application of the EWGSOP algorithm for sarcopenia case finding in the GLISTEN sample.

References

    1. Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, et al Sarcopenia in daily practice: assessment and management. BMC Geriatr 2016;16:170.
    1. Cruz‐Jentoft AJ, Landi F, Topinková E, Michel J‐P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010;13:1–7.
    1. Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012;31:652–658.
    1. Landi F, Cruz‐Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, et al Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 2013;42:203–209.
    1. Cruz‐Jentoft AJ, Landi F. Sarcopenia. Clin Med (Northfield Il) 2014;14:183–186.
    1. Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, et al The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2016;71:259–264.
    1. Cruz‐Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al European Working Group on Sarcopenia in Older People Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–423.
    1. Cruz‐Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, et al Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014;43:748–759.
    1. Bianchi L, Pasquale A, Bellelli G, et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the Glisten study. J Gerontol A Biol Sci Med Sci 2017; .
    1. Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 2007;297:1772–1774.
    1. Coker RH, Hays NP, Williams RH, Wolfe RR, Evans WJ. Bed rest promotes reductions in walking speed, functional parameters, and aerobic fitness in older, healthy adults. J Gerontol Ser A Biol Sci Med Sci 2015;70:91–96.
    1. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat‐free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985;41:810–817.
    1. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413–421.
    1. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465–471.
    1. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755–763.
    1. Chien M‐Y, Huang T‐Y, Wu Y‐T. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community‐dwelling elderly people in Taiwan. J Am Geriatr Soc 2008;56:1710–1715.
    1. Shumway‐Cook A, Guralnik JM, Phillips CL, Coppin AK, Ciol MA, Bandinelli S, et al Age‐associated declines in complex walking task performance: the walking InCHIANTI toolkit. J Am Geriatr Soc 2007;55:58–65.
    1. Ferrucci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997;277:728–734.
    1. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433–441.
    1. Shah A, Herbert R, Lewis S, Mahendran R, Platt J, Bhattacharyya B. Screening for depression among acutely ill geriatric inpatients with a short Geriatric Depression Scale. Age Ageing 1997;26:217–221.
    1. Frontera WR, Hughes VA, Lutz KJ, Evans WJ. A cross‐sectional study of muscle strength and mass in 45‐ to 78‐yr‐old men and women. J Appl Physiol 1991;71:644–650.
    1. Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C. Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 2009;35:28–35.
    1. Marcus RL, Addison O, Dibble LE, Foreman KB, Morrell G, Lastayo P. Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals. J Aging Res 2012;2012:629637.
    1. Landi F, Calvani R, Tosato M, Martone AM, Fusco D, Sisto A, et al Age‐related variations of muscle mass, strength, and physical performance in community‐dwellers: results from the Milan EXPO survey. J Am Med Dir Assoc 2017;18:88.e17–88.e24.
    1. Cerri AP, Bellelli G, Mazzone A, Pittella F, Landi F, Zambon A, et al Sarcopenia and malnutrition in acutely ill hospitalized elderly: prevalence and outcomes. Clin Nutr 2015;34:745–751.
    1. Martone AM, Onder G, Vetrano DL, Ortolani E, Tosato M, Marzetti E, et al Anorexia of aging: a modifiable risk factor for frailty. Forum Nutr 2013;5:4126–4133.
    1. Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Barillaro C, et al Association of anorexia with sarcopenia in a community‐dwelling elderly population: results from the ilSIRENTE study. Eur J Nutr 2013;52:1261–1268.
    1. Cramer JT, Cruz‐Jentoft AJ, Landi F, Hickson M, Zamboni M, Pereira SL, et al Impacts of high‐protein oral nutritional supplements among malnourished men and women with sarcopenia: a multicenter, randomized, double‐blinded, controlled trial. J Am Med Dir Assoc 2016;17:1044–1055.
    1. Landi F, Calvani R, Tosato M, Martone AM, Ortolani E, Savera G, et al Protein intake and muscle health in old age: from biological plausibility to clinical evidence. Forum Nutr 2016;8.
    1. Marzetti E, Calvani R, Tosato M, Cesari M, Di Bari M, Cherubini A, et al SPRINTT Consortium Physical activity and exercise as countermeasures to physical frailty and sarcopenia. Aging Clin Exp Res 2017;29:35–42.
    1. Tosato M, Marzetti E, Cesari M, Savera G, Miller RR, Bernabei R, et al Measurement of muscle mass in sarcopenia: from imaging to biochemical markers. Aging Clin Exp Res 2017;29:19–27.
    1. Binay Safer V, Geler Kulcu D. Bioimpedance analysis and frailty. J Am Geriatr Soc 2015;63:1050–1050.
    1. Lardiés‐Sáncheza B, Sanz‐Parisa A, Boj‐Carcellera D, Cruz‐Jentoft AJ. Systematic review: prevalence of sarcopenia in ageing people using bioelectrical impedance analysis to assess muscle mass. Eur Geriatr Med 2016;7:256–261.
    1. Landi F, Cherubini A, Cesari M, Calvani R, Tosato M, Sisto A, et al Sarcopenia and frailty: from theoretical approach into clinical practice. Eur Geriatr Med 2016;7.
    1. Cesari M, Marzetti E, Calvani R, Vellas B, Bernabei R, Bordes P, et al SPRINTT consortium The need of operational paradigms for frailty in older persons: the SPRINTT project. Aging Clin Exp Res 2017;29:3–10.
    1. Landi F, Calvani R, Cesari M, Tosato M, Martone AM, Bernabei R, et al Sarcopenia as the biological substrate of physical frailty. Clin Geriatr Med 2015;31:367–374.
    1. Jung H‐W, Kim S‐W, Lim J‐Y, Kim K‐W, Jang HC, Kim C‐H, et al Frailty status can predict further lean body mass decline in older adults. J Am Geriatr Soc 2014;62:2110–2117.
    1. Landi F, Calvani R, Ortolani E, Salini S, Martone AM, Santoro L, et al The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in‐hospital rehabilitation. Osteoporos Int 2017.
    1. Chiles Shaffer N, Ferrucci L, Shardell M, Simonsick EM, Studenski S. Agreement and predictive validity using less‐conservative foundation for the National Institutes of Health Sarcopenia Project Weakness Cutpoints. J Am Geriatr Soc 2017;65:574–579.
    1. von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015. J Cachexia Sarcopenia Muscle 2015;6: 315–316.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj